ReNerve Limited (ASX:RNV)

ReNerve Statistics

Total Valuation

ReNerve has a market cap or net worth of AUD 15.51 million. The enterprise value is 11.49 million.

Market Cap	15.51M
Enterprise Value	11.49M

Important Dates

The last earnings date was Wednesday, March 4, 2026.

Earnings Date	Mar 4, 2026
Ex-Dividend Date	n/a

Share Statistics

ReNerve has 172.30 million shares outstanding. The number of shares has increased by 44.82% in one year.

Current Share Class	172.30M
Shares Outstanding	172.30M
Shares Change (YoY)	+44.82%
Shares Change (QoQ)	+3.52%
Owned by Insiders (%)	28.58%
Owned by Institutions (%)	2.23%
Float	88.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	46.54
PB Ratio	2.91
P/TBV Ratio	2.95
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.49
EV / Sales	34.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.56

Financial Position

The company has a current ratio of 6.77, with a Debt / Equity ratio of 0.03.

Current Ratio	6.77
Quick Ratio	6.07
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-20.91

Financial Efficiency

Return on equity (ROE) is -74.94% and return on invested capital (ROIC) is -52.34%.

Return on Equity (ROE)	-74.94%
Return on Assets (ROA)	-47.64%
Return on Invested Capital (ROIC)	-52.34%
Return on Capital Employed (ROCE)	-96.65%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.05
Inventory Turnover	0.61

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.00% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-25.00%
50-Day Moving Average	0.11
200-Day Moving Average	0.11
Relative Strength Index (RSI)	36.46
Average Volume (20 Days)	161,885

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ReNerve had revenue of AUD 333,211 and -4.61 million in losses. Loss per share was -0.03.

Revenue	333,211
Gross Profit	188,230
Operating Income	-5.22M
Pretax Income	-4.61M
Net Income	-4.61M
EBITDA	-5.18M
EBIT	-5.22M
Loss Per Share	-0.03

Balance Sheet

The company has 4.19 million in cash and 164,299 in debt, with a net cash position of 4.02 million or 0.02 per share.

Cash & Cash Equivalents	4.19M
Total Debt	164,299
Net Cash	4.02M
Net Cash Per Share	0.02
Equity (Book Value)	5.32M
Book Value Per Share	0.03
Working Capital	5.00M

Cash Flow

In the last 12 months, operating cash flow was -4.39 million and capital expenditures -98,760, giving a free cash flow of -4.49 million.

Operating Cash Flow	-4.39M
Capital Expenditures	-98,760
Depreciation & Amortization	33,582
Net Borrowing	-30,916
Free Cash Flow	-4.49M
FCF Per Share	-0.03

Margins

Gross Margin	56.49%
Operating Margin	-1,565.56%
Pretax Margin	-1,382.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ReNerve does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.82%
Shareholder Yield	-44.82%
Earnings Yield	-29.71%
FCF Yield	-28.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ReNerve has an Altman Z-Score of 5.74 and a Piotroski F-Score of 2.

Altman Z-Score	5.74
Piotroski F-Score	2